FRMM NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

Forum Markets, Incorporated · Technology · Software - Application

Open interactive chart View report data
Latest close 6.02 USD
16.7% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 35.7% above the Trend Line and sits at 2.5% of its 52-week range. The latest completed week returned 16.7%, after a 1.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 49/100 conviction, while the latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 42 out of 100
Latest Close 6.02 USD 7 Aug 2026
1W Return 16.7% latest completed week
4W Return 1.0% short-term follow-through
12W Return 62.7% quarterly tape
Trend Breadth 30.8% 16 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • 5 accumulation markers appear in the recent smart-money tape.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 34.77% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 16.7% Latest completed week; four-week move 1.0%. Indicator stack 34/77 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 34.77% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 49/100 conviction; expected move 31.1%. News sentiment 50/100 22 relevant articles in the latest sentiment read. Event risk 13 Aug Latest stored earnings date was 13 Aug 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 35.7% above the Trend Line and sits at 2.5% of its 52-week range. The latest completed week returned 16.7%, after a 1.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3412-week average 0.29

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.34Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

5 accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.0% over four weeks, 62.7% over 12 weeks, and -79.9% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W16.7%
4W1.0%
12W62.7%
26W74.0%
52W-79.9%
Active trend streak5 weeks
Active weeks in one year16
Trend breadth30.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.51Latest activity-pressure read.
Pressure change0.3%Four-week change in activity pressure.
Leadership-52.76Latest relative-leadership reading.
RS change13.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 73% Model confidence 68%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength63/100Blend of value, momentum, and quality. Underlying universe rank 38; rank 1 is best.
Value56/100Relative valuation strength. Underlying universe rank 45; rank 1 is best.
Quality53/100Profitability and accounting quality. Underlying universe rank 48; rank 1 is best.
Momentum56/100Medium-term price momentum. Underlying universe rank 45; rank 1 is best.
Growth56/100Revenue and earnings growth. Underlying universe rank 45; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
8.5x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-70.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
69.6%
Gross profit retained from each unit of revenue.
Operating margin
-3345.6%
Operating profit retained from revenue.
Free-cash-flow margin
-306.6%
Free cash flow generated from revenue.
Return on invested capital
-182.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-
Net share repurchases relative to market value.
Shareholder yield
-
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

FRMM shows volatility options pressure with a 49/100 conviction score, put-call volume ratio of 0.09, expected move of 31.1%, and Sharemaestro trend signal active.

Conviction49/100
Expected move31.1%
Put/call volume0.09
Pressure92
Speculation4
Volatility96
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 22 relevant articles.

1 positive · 20 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings13 AugLatest stored earnings date was 13 Aug 2026.
Options expected move31.1%Nearest-chain priced movement where available.
52-week drawdown-96.6%Distance below the 52-week high.
13-week volatility11.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2612 weeks finished lower.
Best week+118.9%Week of 17 Apr.
Worst week-28.7%Week of 10 Apr.
Latest week+16.7%Week of 7 Aug.

Shape of recent returns

Strong gains9
Modest gains4
Flat weeks1
Modest losses4
Sharp losses8
Recent vol11.3%13-week weekly-return volatility.
Base vol29.2%52-week weekly-return volatility.
Up/down split20/31Count of positive and negative weeks in the 52-week window.
Average skew21.0% / -13.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape35/100

Trend, activity pressure, participation, and risk combine to a 35/100 tape read.

 Indicator analysis53/100

Latest 12-week confirmation: trend 5/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.34; No reversal markers Next-Week ExpectancyNegative 34.77%

Next-week expectancy is negative with a 34.77% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors56/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50; Small Cap Core rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options35/100

FRMM shows volatility options pressure with a 49/100 conviction score, put-call volume ratio of 0.09, expected move of 31.1%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 31.1% Sentiment50/100

Weighted news tone is neutral across 22 relevant articles.

FRMM|Forum Markets Ord Shs|Price:5.260|Chg%:-0.060 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings13 Aug

Latest stored earnings date was 13 Aug 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20266.02 USD16.7%4.44 USD25.57 USD1.51-52.761.5MOn
31 Jul 20265.16 USD-9.9%4.40 USD26.41 USD1.64-59.40921.6KOn
24 Jul 20265.73 USD0.9%4.39 USD27.36 USD1.76-57.191.5MOn
17 Jul 20265.68 USD-4.7%4.38 USD28.44 USD1.70-60.002.1MOn
10 Jul 20265.96 USD-1.0%4.42 USD29.70 USD1.51-60.722.3MOn
3 Jul 20266.02 USD7.9%4.48 USD30.93 USD1.36-59.911.1MOff
26 Jun 20265.58 USD10.5%4.63 USD32.24 USD1.23-62.771.5MOff
19 Jun 20265.05 USD-5.6%4.80 USD33.63 USD1.10-68.031.1MOff
12 Jun 20265.35 USD5.1%4.98 USD34.98 USD1.01-65.531.4MOff
5 Jun 20265.09 USD14.9%5.30 USD36.37 USD0.89-66.781.9MOff
29 May 20264.43 USD-2.4%5.73 USD37.82 USD0.81-72.691.2MOff
22 May 20264.54 USD22.7%6.23 USD39.24 USD0.82-71.551.6MOff
15 May 20263.70 USD-19.7%6.68 USD40.64 USD0.84-76.782.1MOff
8 May 20264.61 USD-21.2%7.12 USD42.14 USD0.94-71.591.7MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context